KLOW Stack (80mg)

KLOW Stack (80mg)

$174.99
$174.99
SAVE Sold out

✔ Verified 99+% Purity

✔ Third-Party Approved & Tested

✔ Fast Australian Shipping

Research Use Only

This product is sold for research purposes only. It is not intended for human or animal consumption. By purchasing this product, you confirm that you are a qualified researcher or are purchasing for legitimate research purposes.

Bacteriostatic Water (20mg)
Add Bacteriostatic Water (20mg)
Required for reconstitution
$24.99
KLOW Stack (80mg)

KLOW Stack (80mg)

$174.99
$174.99
SAVE Sold out

Shipping Information

Orders are processed and dispatched within 24 hours of payment confirmation (Monday–Friday). Delivery typically arrives within 1–4 business days via Standard post, and 1-2 business days via Express post.

View full details

KLOW

Supplied as a lyophilized (freeze-dried) powder in a sealed sterile vial. Requires reconstitution with bacteriostatic water prior to use. Each vial contains an 80mg four-peptide blend at high purity, combining GHK-Cu, BPC-157, TB-500, and KPV in a single formulation.

KLOW is a distinct formulation from GLOW rather than a variant of it. Where GLOW is positioned around dermal structural repair, KLOW extends the concept toward broader anti-inflammatory and recovery research, combining all four peptides in one vial for protocols studying tissue regeneration, immune modulation, gut-barrier function, and recovery. GHK-Cu is studied for collagen signalling and tissue remodelling; BPC-157 and TB-500 are studied for angiogenesis, connective-tissue repair, and cellular migration; KPV — a tripeptide fragment derived from the C-terminus of alpha-MSH — shifts the blend toward anti-inflammatory and immune-modulating research, including gut-lining models.

Research Background

Research into multi-peptide blends like KLOW typically examines how complementary mechanisms interact when studied together rather than in isolation. GHK-Cu's role in fibroblast activity and gene expression has been studied alongside BPC-157 and TB-500's documented effects on angiogenesis, actin cytoskeletal regulation, and cellular migration in tissue repair models. KPV, meanwhile, has been examined for its ability to inhibit NF-κB signalling and modulate cytokine expression — including in intestinal epithelial models — independent of classical melanocortin receptor activation. Combining these four peptides allows researchers to study structural repair, vascular and connective-tissue regeneration, and inflammatory modulation within a single research protocol.

Key Research Areas
Tissue regeneration — collagen signalling, repair-cell mobilisation, angiogenesis, and structural remodelling
Inflammatory signalling — BPC-157 and KPV studied for anti-inflammatory and immune-modulating activity
Gut-skin axis research — KPV relevant to barrier integrity and gut-linked inflammatory models
Connective tissue models — BPC-157 and TB-500 studied across muscle, tendon, ligament, and soft-tissue repair
Dermal research — GHK-Cu studied for collagen, elastin, and dermal structural protein synthesis
Studied Mechanisms
Copper ion cofactor activity supporting fibroblast and collagen synthesis (GHK-Cu)
VEGF upregulation and actin cytoskeletal modulation supporting angiogenesis (BPC-157 / TB-500)
NF-κB pathway inhibition and cytokine modulation independent of MC1R activation (KPV)
Intestinal epithelial barrier and mucosal integrity modulation (KPV)
Combined/additive signalling across structural, vascular, and inflammatory pathways

Product Specifications

CategoryTissue Repair Research
CoA CompositionGHK-Cu 55.48mg · BPC-157 10.80mg · TB-500 10.23mg · KPV 11.06mg
FormLyophilised Powder
ReconstitutionBacteriostatic water (recommended)
Purity≥99% (HPLC Verified)
StorageStore at -20°C, away from light and moisture
Research Use Only

This product is strictly intended for in vitro laboratory research purposes only. It is not approved for human or veterinary use, and is not intended for consumption, injection, or any therapeutic application.